KRAS and metastatic melanoma: Moreover, the proliferation pathway was negatively enriched and the KRAS signaling down pathway was positively enriched across the majority of cells independent of the status of PANoptosis score (Fig. 6B), thereby providing insights into dysregulation of these pathways in patients with metastatic melanoma for individual cells at the single cell resolution.